Letter: Incidence of congenital limb-reduction deformities.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D001132:Arm / Q000002:abnormalities*; D001593:Benzyl Compounds / Q000009:adverse effects; D001724:Birth Weight; D000013:Congenital Abnormalities / Q000453:epidemiology* / Q000209:etiology; D004739:England; D004917:Erythromycin / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005003:Ethisterone / Q000009:adverse effects; D005029:Ethylenediamines / Q000009:adverse effects; D005260:Female; D005385:Fingers / Q000002:abnormalities; D006215:Hallux Valgus / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D007866:Leg / Q000002:abnormalities*; D008297:Male; D008423:Maternal Age; D008468:Meclizine / Q000009:adverse effects; D009640:Norethindrone / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects; D011736:Pyridoxine / Q000009:adverse effects; D012621:Seasons; D013420:Sulfamethoxazole / Q000009:adverse effects; D013977:Tibia / Q000002:abnormalities; D014295:Trimethoprim / Q000009:adverse effects
D001593:Benzyl Compounds; D005029:Ethylenediamines; D011725:Pyridines; D008468:Meclizine; D004997:Ethinyl Estradiol; D004917:Erythromycin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D011736:Pyridoxine; D005003:Ethisterone; D009640:Norethindrone